Renovacor Announces the Appointment of Fred Driscoll as Chief Financial Officer – BioSpace

Mr. Driscoll has over 25 years of biotech executive experience and most recently served as the CFO of Flexion Therapeutics through its sale to Pacira BioSciences for up to $1 billion PHILADELPHIA–(BUSINESS WIRE)– Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and families battling …

Renovacor Announces the Appointment of Fred Driscoll as Chief Financial Officer – BioSpace Read More »